Accès ouvert
2026
review
OpenAlex
Sadia Yousaf, Maryam Akhtar, Uswah Ilyas, Maham Fatima et autres
2026
article
OpenAlex
Beenish Sabir, Haris Mumtaz Malik, Abdullah Bin Kamran, Amina Khan et autres
This study evaluates the efficacy of re-irradiation combined with bevacizumab compared to bevacizumab alone in treating recurrent glioblastoma.
pk, us
(code pays fourni par la source)
Accès ouvert
2026
conference-abstract
OpenAlex
FNU Sawaira, Aizaz Anwar Khalid, Owais Gul, Muhammad Waqas et autres
e20038 Background: Elderly patients with medically inoperable stage I non–small cell lung cancer (NSCLC) are commonly treated with radiation therapy. While stereotactic body radiotherapy (SBRT) is widely used, its benefits compared with conventional and hypofractionated radiotherapy in this population remain debated. We …
pk, us
(code pays fourni par la source)
Accès ouvert
2025
review
OpenAlex
Iftikhar Hussain Khan, Soban Ali Qasim, Haris Mumtaz Malik, Muhammad Hamza et autres
BACKGROUND: The optimal timing of laparoscopic appendectomy for acute uncomplicated appendicitis remains uncertain. We performed a systematic review and meta-analysis to compare operative and safety outcomes following early versus delayed laparoscopic appendectomy in adults. METHODS: PubMed, Cochrane Central, and ClinicalTrials.gov were searched …
pk, af, us
(code pays fourni par la source)
Accès ouvert
2025
review
OpenAlex
Iftikhar Mohammad Khan, Soban Ali Qasim, Shree Rath, Haris Mumtaz Malik et autres
BACKGROUND: Immune thrombocytopenia (ITP) is an autoimmune condition often managed with corticosteroids, intravenous immunoglobulins, or thrombopoietin receptor agonists. In settings where these therapies are inaccessible or contraindicated, dapsone an older antimicrobial agent with immunomodulatory effects has been proposed as an alternative, though …
pk, in, jo, af
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Haris Mumtaz Malik, Beenish Sabir, Adnan Bhat, Waseem Nabi et autres
Introduction: Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the gold-standard surgical treatment for ulcerative colitis and familial adenomatous polyposis. While IPAA preserves continence and avoids a permanent stoma, it carries risks such as pouchitis and pouch failure. Pelvic radiation, used for …
2025
conference-abstract
OpenAlex
Haris Mumtaz Malik, Arun Kumar Maloth, Adnan Bhat, Muhammad Ansab et autres
Introduction: Tislelizumab, a humanized anti–programmed cell death protein 1 monoclonal antibody, has shown promising antitumor activity in esophageal squamous cell carcinoma (ESCC), a malignancy with poor prognosis and limited therapeutic options. While individual studies report variable outcomes, a comprehensive meta-analysis quantifying its …
2025
article
OpenAlex
DR.ANUM IJAZ, Anurag Jha, Muhammad Nabeel Saddique, Mustafa Shehzad et autres
Accès ouvert
2025
preprint
OpenAlex
Beenish Sabir, Areeba, M. Ali Babar, Haris Mumtaz Malik et autres
pk
(code pays fourni par la source)
2025
article
OpenAlex
Shariq Ahmad Wani, Mir Wajid Majeed, Paweł Marek Łajczak, Ayesha Ayesha et autres
e21512 Background: The standard treatment for resectable, macroscopic stage 3 melanoma is Surgery followed by adjuvant therapy but neoadjuvant combination immune checkpoint inhibitor(ICI) therapy has shown to significantly increase the survival of patients. This proportional systematic review and metaanalysis aims to evaluate …
in, pl, pk, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Aman Ullah, Faseeh Haider, Adnan Bhat, Vatsal Makhija et autres
e20593 Background: Tislelizumab, an anti-PD-1 antibody, is emerging as a promising immunotherapy agent and has demonstrated clinical benefit and acceptable tolerability in recent lung cancer trials. This study aims to assess the safety and efficacy of Tislelizumab, as monotherapy or combined with …
us, pk, in
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Haris Mumtaz Malik, Ramzan Hassan Farooq, Faraz Ali, Beenish Sabir et autres
e18545 Background: Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are key indications for hematopoietic stem cell transplantation (HSCT). While the Busulfan-Cyclophosphamide (BuCy) regimen has been a standard, it carries high risks of hepatic veno-occlusive disease (HVOD) and non-relapse mortality (NRM), especially …
pk, us, qa
(code pays fourni par la source)